Literature DB >> 30169739

Drug Gene Budger (DGB): an application for ranking drugs to modulate a specific gene based on transcriptomic signatures.

Zichen Wang1, Edward He1, Kevin Sani1, Kathleen M Jagodnik1, Moshe C Silverstein1, Avi Ma'ayan1.   

Abstract

SUMMARY: Mechanistic molecular studies in biomedical research often discover important genes that are aberrantly over- or under-expressed in disease. However, manipulating these genes in an attempt to improve the disease state is challenging. Herein, we reveal Drug Gene Budger (DGB), a web-based and mobile application developed to assist investigators in order to prioritize small molecules that are predicted to maximally influence the expression of their target gene of interest. With DGB, users can enter a gene symbol along with the wish to up-regulate or down-regulate its expression. The output of the application is a ranked list of small molecules that have been experimentally determined to produce the desired expression effect. The table includes log-transformed fold change, P-value and q-value for each small molecule, reporting the significance of differential expression as determined by the limma method. Relevant links are provided to further explore knowledge about the target gene, the small molecule and the source of evidence from which the relationship between the small molecule and the target gene was derived. The experimental data contained within DGB is compiled from signatures extracted from the LINCS L1000 dataset, the original Connectivity Map (CMap) dataset and the Gene Expression Omnibus (GEO). DGB also presents a specificity measure for a drug-gene connection based on the number of genes a drug modulates. DGB provides a useful preliminary technique for identifying small molecules that can target the expression of a single gene in human cells and tissues.
AVAILABILITY AND IMPLEMENTATION: The application is freely available on the web at http://DGB.cloud and as a mobile phone application on iTunes https://itunes.apple.com/us/app/drug-gene-budger/id1243580241? mt=8 and Google Play https://play.google.com/store/apps/details? id=com.drgenebudger. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 30169739      PMCID: PMC6449747          DOI: 10.1093/bioinformatics/bty763

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.931


  8 in total

1.  The sva package for removing batch effects and other unwanted variation in high-throughput experiments.

Authors:  Jeffrey T Leek; W Evan Johnson; Hilary S Parker; Andrew E Jaffe; John D Storey
Journal:  Bioinformatics       Date:  2012-01-17       Impact factor: 6.937

2.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

3.  The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.

Authors:  Justin Lamb; Emily D Crawford; David Peck; Joshua W Modell; Irene C Blat; Matthew J Wrobel; Jim Lerner; Jean-Philippe Brunet; Aravind Subramanian; Kenneth N Ross; Michael Reich; Haley Hieronymus; Guo Wei; Scott A Armstrong; Stephen J Haggarty; Paul A Clemons; Ru Wei; Steven A Carr; Eric S Lander; Todd R Golub
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

4.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

5.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.

Authors:  Aravind Subramanian; Rajiv Narayan; Steven M Corsello; David D Peck; Ted E Natoli; Xiaodong Lu; Joshua Gould; John F Davis; Andrew A Tubelli; Jacob K Asiedu; David L Lahr; Jodi E Hirschman; Zihan Liu; Melanie Donahue; Bina Julian; Mariya Khan; David Wadden; Ian C Smith; Daniel Lam; Arthur Liberzon; Courtney Toder; Mukta Bagul; Marek Orzechowski; Oana M Enache; Federica Piccioni; Sarah A Johnson; Nicholas J Lyons; Alice H Berger; Alykhan F Shamji; Angela N Brooks; Anita Vrcic; Corey Flynn; Jacqueline Rosains; David Y Takeda; Roger Hu; Desiree Davison; Justin Lamb; Kristin Ardlie; Larson Hogstrom; Peyton Greenside; Nathanael S Gray; Paul A Clemons; Serena Silver; Xiaoyun Wu; Wen-Ning Zhao; Willis Read-Button; Xiaohua Wu; Stephen J Haggarty; Lucienne V Ronco; Jesse S Boehm; Stuart L Schreiber; John G Doench; Joshua A Bittker; David E Root; Bang Wong; Todd R Golub
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

6.  DrugBank 4.0: shedding new light on drug metabolism.

Authors:  Vivian Law; Craig Knox; Yannick Djoumbou; Tim Jewison; An Chi Guo; Yifeng Liu; Adam Maciejewski; David Arndt; Michael Wilson; Vanessa Neveu; Alexandra Tang; Geraldine Gabriel; Carol Ly; Sakina Adamjee; Zerihun T Dame; Beomsoo Han; You Zhou; David S Wishart
Journal:  Nucleic Acids Res       Date:  2013-11-06       Impact factor: 16.971

7.  eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks.

Authors:  Daniel J B Clarke; Maxim V Kuleshov; Brian M Schilder; Denis Torre; Mary E Duffy; Alexandra B Keenan; Alexander Lachmann; Axel S Feldmann; Gregory W Gundersen; Moshe C Silverstein; Zichen Wang; Avi Ma'ayan
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 19.160

8.  Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd.

Authors:  Zichen Wang; Caroline D Monteiro; Kathleen M Jagodnik; Nicolas F Fernandez; Gregory W Gundersen; Andrew D Rouillard; Sherry L Jenkins; Axel S Feldmann; Kevin S Hu; Michael G McDermott; Qiaonan Duan; Neil R Clark; Matthew R Jones; Yan Kou; Troy Goff; Holly Woodland; Fabio M R Amaral; Gregory L Szeto; Oliver Fuchs; Sophia M Schüssler-Fiorenza Rose; Shvetank Sharma; Uwe Schwartz; Xabier Bengoetxea Bausela; Maciej Szymkiewicz; Vasileios Maroulis; Anton Salykin; Carolina M Barra; Candice D Kruth; Nicholas J Bongio; Vaibhav Mathur; Radmila D Todoric; Udi E Rubin; Apostolos Malatras; Carl T Fulp; John A Galindo; Ruta Motiejunaite; Christoph Jüschke; Philip C Dishuck; Katharina Lahl; Mohieddin Jafari; Sara Aibar; Apostolos Zaravinos; Linda H Steenhuizen; Lindsey R Allison; Pablo Gamallo; Fernando de Andres Segura; Tyler Dae Devlin; Vicente Pérez-García; Avi Ma'ayan
Journal:  Nat Commun       Date:  2016-09-26       Impact factor: 14.919

  8 in total
  9 in total

1.  OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features.

Authors:  Billy Zeng; Benjamin S Glicksberg; Patrick Newbury; Evgeny Chekalin; Jing Xing; Ke Liu; Anita Wen; Caven Chow; Bin Chen
Journal:  Nat Protoc       Date:  2020-12-23       Impact factor: 13.491

Review 2.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

3.  Connectivity Mapping Identifies BI-2536 as a Potential Drug to Treat Diabetic Kidney Disease.

Authors:  Lu Zhang; Zichen Wang; Ruijie Liu; Zhengzhe Li; Jennifer Lin; Megan L Wojciechowicz; Jiyi Huang; Kyung Lee; Avi Ma'ayan; John Cijiang He
Journal:  Diabetes       Date:  2020-10-16       Impact factor: 9.461

4.  Colon Cancer Progression Is Reflected to Monotonic Differentiation in Gene Expression and Pathway Deregulation Facilitating Stage-specific Drug Repurposing.

Authors:  Marilena M Bourdakou; George M Spyrou; George Kolios
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

5.  Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential Therapeutics.

Authors:  Broto Chakrabarty; Dibyajyoti Das; Gopalakrishnan Bulusu; Arijit Roy
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2021-08-06       Impact factor: 3.702

6.  DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.

Authors:  Jie Lyu; Jingyi Jessica Li; Jianzhong Su; Fanglue Peng; Yiling Elaine Chen; Xinzhou Ge; Wei Li
Journal:  Sci Adv       Date:  2020-11-11       Impact factor: 14.136

7.  On tower and checkerboard neural network architectures for gene expression inference.

Authors:  Vladimír Kunc; Jiří Kléma
Journal:  BMC Genomics       Date:  2020-12-16       Impact factor: 3.969

Review 8.  Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.

Authors:  Trang T T Truong; Bruna Panizzutti; Jee Hyun Kim; Ken Walder
Journal:  Pharmaceutics       Date:  2022-07-14       Impact factor: 6.525

9.  Translating in vitro CFTR rescue into small molecule correctors for cystic fibrosis using the Library of Integrated Network-based Cellular Signatures drug discovery platform.

Authors:  Matthew D Strub; Shyam Ramachandran; Dmitri Y Boudko; Ella A Meleshkevitch; Alejandro A Pezzulo; Aravind Subramanian; Arthur Liberzon; Robert J Bridges; Paul B McCray
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.